403 related articles for article (PubMed ID: 30094536)
21. Cutaneous malignant melanoma: from early diagnosis to gene therapy.
Reinhold U
Bull Mem Acad R Med Belg; 2001; 156(3-4):212-6; discussion 216-8. PubMed ID: 11789400
[TBL] [Abstract][Full Text] [Related]
22. Combinatorial immunotherapy for melanoma.
George DD; Armenio VA; Katz SC
Cancer Gene Ther; 2017 Mar; 24(3):141-147. PubMed ID: 27834353
[TBL] [Abstract][Full Text] [Related]
23. Nanosystems for Improved Targeted Therapies in Melanoma.
Beiu C; Giurcaneanu C; Grumezescu AM; Holban AM; Popa LG; Mihai MM
J Clin Med; 2020 Jan; 9(2):. PubMed ID: 31979325
[TBL] [Abstract][Full Text] [Related]
24. Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy.
Brys AK; Gowda R; Loriaux DB; Robertson GP; Mosca PJ
Biotechnol Adv; 2016; 34(5):565-577. PubMed ID: 26826558
[TBL] [Abstract][Full Text] [Related]
25. The Treatment of Melanoma Brain Metastases.
Kibbi N; Kluger H
Curr Oncol Rep; 2016 Dec; 18(12):73. PubMed ID: 27822695
[TBL] [Abstract][Full Text] [Related]
26. Mycobacterium bovis BCG in metastatic melanoma therapy.
Benitez MLR; Bender CB; Oliveira TL; Schachtschneider KM; Collares T; Seixas FK
Appl Microbiol Biotechnol; 2019 Oct; 103(19):7903-7916. PubMed ID: 31402426
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in nanotechnology based combination drug therapy for skin cancer.
Kumari S; Choudhary PK; Shukla R; Sahebkar A; Kesharwani P
J Biomater Sci Polym Ed; 2022 Aug; 33(11):1435-1468. PubMed ID: 35294334
[TBL] [Abstract][Full Text] [Related]
28. Current therapy for malignant melanoma.
Legha SS
Semin Oncol; 1989 Feb; 16(1 Suppl 1):34-44. PubMed ID: 2465575
[TBL] [Abstract][Full Text] [Related]
29. [Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute].
Leccia MT; Planchamp F; Sassolas B; Combemale P; Modiano P; Bedane C; Cupissol D; Derrey S; Dygai-Cochet I; Lamant L; Lubrano V; Mirabel X; Mourrégot A; Rougé Bugat ME; Siegrist S; Thariat J; Tiffet O; Truc G; Verdoni L; Mazeau-Woynar V
Ann Dermatol Venereol; 2014 Feb; 141(2):111-21. PubMed ID: 24507205
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous Melanoma-A Review in Detection, Staging, and Management.
Hartman RI; Lin JY
Hematol Oncol Clin North Am; 2019 Feb; 33(1):25-38. PubMed ID: 30497675
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and treatment of malignant melanoma].
Ishihara K; Ikegawa S
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1727-34. PubMed ID: 2412493
[TBL] [Abstract][Full Text] [Related]
32. Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape.
Zigler M; Villares GJ; Lev DC; Melnikova VO; Bar-Eli M
Am J Clin Dermatol; 2008; 9(5):307-11. PubMed ID: 18717605
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic strategies and systemic treatment of brain melanoma metastases].
Durando X; Mansard S; Daste A; Gimbergues P; Brocard L; Magné N; Thivat E
Bull Cancer; 2013 Jan; 100(1):23-8. PubMed ID: 22889847
[TBL] [Abstract][Full Text] [Related]
34. Novel Targets in Melanoma: Intralesional and Combination Therapy to Manipulate the Immune Response.
Gingrich AA; Kirane AR
Surg Oncol Clin N Am; 2020 Jul; 29(3):467-483. PubMed ID: 32482321
[TBL] [Abstract][Full Text] [Related]
35. NCCN Guidelines Insights: Melanoma, Version 3.2016.
Coit DG; Thompson JA; Algazi A; Andtbacka R; Bichakjian CK; Carson WE; Daniels GA; DiMaio D; Fields RC; Fleming MD; Gastman B; Gonzalez R; Guild V; Johnson D; Joseph RW; Lange JR; Martini MC; Materin MA; Olszanski AJ; Ott P; Gupta AP; Ross MI; Salama AK; Skitzki J; Swetter SM; Tanabe KK; Torres-Roca JF; Trisal V; Urist MM; McMillian N; Engh A
J Natl Compr Canc Netw; 2016 Aug; 14(8):945-58. PubMed ID: 27496110
[TBL] [Abstract][Full Text] [Related]
36. Advances in Carbon Nanotubes for Malignant Melanoma: A Chance for Treatment.
de Carvalho Lima EN; Piqueira JRC; Maria DA
Mol Diagn Ther; 2018 Dec; 22(6):703-715. PubMed ID: 30368765
[TBL] [Abstract][Full Text] [Related]
37. Frontline approach to metastatic BRAF-mutant melanoma diagnosis, molecular evaluation, and treatment choice.
Chapman PB; Hauschild A; Sondak VK
Am Soc Clin Oncol Educ Book; 2014; ():e412-21. PubMed ID: 24857132
[TBL] [Abstract][Full Text] [Related]
38. Drug Combinations as the New Standard for Melanoma Treatment.
Polkowska M; Czepielewska E; Kozłowska-Wojciechowska M
Curr Treat Options Oncol; 2016 Dec; 17(12):61. PubMed ID: 27766547
[TBL] [Abstract][Full Text] [Related]
39. Current Treatment of Melanoma Brain Metastasis.
Rishi A; Yu HM
Curr Treat Options Oncol; 2020 Apr; 21(6):45. PubMed ID: 32350685
[TBL] [Abstract][Full Text] [Related]
40. Indications and options for systemic therapy in melanoma.
Sondak VK; Gibney GT
Surg Clin North Am; 2014 Oct; 94(5):1049-58, viii. PubMed ID: 25245967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
